查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1609020

更年期潮熱市場：按治療類型、分銷管道分類 - 全球預測 2025-2030

Menopausal Hot Flashes Market by Treatment Type (Alternative Treatment, Hormonal Treatment, Non-Hormonal Treatment), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年更年期潮熱市場價值為82.4億美元，預計到2024年將達到86.4億美元，複合年成長率為6.18%，到2030年將達到125.4億美元。

更年期潮熱的特徵是突然發熱和出汗，主要影響更年期女性。市場研究範圍包括評估潮熱的盛行率、受影響最嚴重的人群、各種治療方案（包括荷爾蒙療法和非荷爾蒙療法）的有效性以及患者的偏好。潮熱引起的極大不適影響了生活品質，因此需要有效的解決方案。這項研究的應用範圍從藥物到自然療法，最終用途延伸到醫療保健提供者和患者本身。市場開拓的主要驅動力包括女性意識的提高、治療方案的進步以及製藥公司對研發的大力投資。最近的機會在於數位健康解決方案和個人化醫療方法的整合，以滿足患者的獨特需求。為了利用這些機會，公司應專注於與高科技公司合作，透過數位平台提高患者的參與度和依從性。相反，監管障礙、荷爾蒙治療相關副作用以及反對談論更年期的文化偏見等挑戰可能會阻礙市場擴張。克服這些問題需要有效的傳播策略和監管應對措施。

主要市場統計
基準年[2023] 82.4億美元
預計年份 [2024] 86.4億美元
預測年份 [2030] 125.4億美元
複合年成長率（%） 6.18%

新興的創新領域包括非荷爾蒙療法的開發，這些療法吸引了那些尋求更安全替代品的人，例如選擇性雌激素受體調節和草藥補充品。此外，使用人工智慧來預測和管理症狀指出了未來的成長途徑。市場本身強勁而充滿活力，在產品開發和服務提供方面具有巨大的創新空間，並呈現出積極的成長軌跡。專注於多通路行銷策略、強大的售後支援和患者教育的公司將能夠提高其市場佔有率並與客戶建立更深入的聯繫。總體而言，利用技術和增加患者偏好對於永續成長非常重要。

市場動態：揭示快速發展的更年期潮熱市場的關鍵市場洞察

供需的動態交互作用正在改變更年期潮熱市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 月經熱患病率上升
    • 提高消費者對更年期健康的認知
  • 市場限制因素
    • 與荷爾蒙製劑相關的副作用
  • 市場機會
    • 介紹先進技術的治療方法
    • 與更年期過渡相關的新意識計劃和宣傳活動
  • 市場挑戰
    • 學名藥的存在

波特五力：駕馭更年期熱潮市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對更年期潮熱市場的影響

外部宏觀環境因素對更年期潮熱市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解更年期潮熱市場的競爭狀況

對更年期潮熱市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣供應商在更年期潮熱市場績效評估

FPNV定位矩陣是評估更年期潮熱市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製更年期潮熱市場的成功之路

對更年期潮熱市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 月經發燒的發生率增加
      • 提高消費者對更年期健康的認知
    • 抑制因素
      • 與荷爾蒙藥物相關的副作用
    • 機會
      • 介紹先進技術的治療方法
      • 更年期過渡意識計畫和宣傳活動的興起
    • 任務
      • 學名藥的存在
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章更年期潮熱市場治療類型

  • 替代治療
    • 黑升麻
    • 草藥
    • 維生素E
  • 荷爾蒙治療
    • 雌激素
    • 雌激素和黃體素的組合
    • 黃體酮
  • 非荷爾蒙治療

第7章更年期潮熱市場：依通路分類

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第8章 北美和南美更年期潮熱市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區更年期潮熱市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲更年期潮熱市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • A.Vogel Ltd.
  • Apotex Inc.
  • Astellas Pharma Inc.
  • Bayer AG
  • Fervent Pharmaceuticals, LLC
  • Glenmark Pharmaceuticals Ltd.
  • Mithra Pharmaceuticals
  • Novartis AG
  • Pfizer Inc.
  • Teva Pharmaceuticals Ltd.
  • TherapeuticsMD, Inc.
  • Zywie Ventures Private Limited
Product Code: MRR-742BD51814A1

The Menopausal Hot Flashes Market was valued at USD 8.24 billion in 2023, expected to reach USD 8.64 billion in 2024, and is projected to grow at a CAGR of 6.18%, to USD 12.54 billion by 2030.

Menopausal hot flashes are characterized by sudden warmth and sweating, primarily affecting women experiencing menopause. The scope of market research encompasses understanding the prevalence of hot flashes, the demographic segments most affected, and evaluating the efficacy and patient preference for various treatment options, including hormonal and non-hormonal therapies. The necessity for effective solutions stems from the significant discomfort hot flashes cause, impacting quality of life. Applications of this research are extensive, ranging from pharmaceuticals to natural remedies, with end-use extending towards healthcare providers and the patients themselves. Key market growth factors include increasing awareness among women, advancements in treatment options, and strong investment in research and development by pharmaceutical companies. Recent opportunities lie in the integration of digital health solutions and personalized medicine approaches that align with patient-specific needs. For businesses to capitalize on these opportunities, they should focus on partnerships with tech companies to enhance patient engagement and adherence through digital platforms. Conversely, challenges such as regulatory hurdles, side effects associated with hormonal treatments, and cultural stigmas about discussing menopause can impede market expansion. Overcoming these requires effective communication strategies and regulatory navigation.

KEY MARKET STATISTICS
Base Year [2023] USD 8.24 billion
Estimated Year [2024] USD 8.64 billion
Forecast Year [2030] USD 12.54 billion
CAGR (%) 6.18%

Emerging areas of innovation include the development of non-hormonal therapeutics, such as selective estrogen receptor modulators and herbal supplements, which appeal to those seeking safer alternatives. Additionally, the use of artificial intelligence to predict and manage symptoms presents a futuristic growth avenue. The market itself is robust yet dynamic, showing a positive growth trajectory with significant room for innovation in product development and service delivery. Companies focusing on multi-channel marketing strategies, robust after-market support, and patient education are likely to enhance their market presence and foster a more profound connection with their customers. Overall, leveraging technology and enhancing patient preference will be crucial for sustained growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Menopausal Hot Flashes Market

The Menopausal Hot Flashes Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of menstrual fever
    • Increasing awareness of menopause health among consumers
  • Market Restraints
    • Associated side effects of hormonal products
  • Market Opportunities
    • Introduction of technologically advanced treatment
    • Emerging awareness programs and campaigns for menopausal transition
  • Market Challenges
    • Presence of generic medicines

Porter's Five Forces: A Strategic Tool for Navigating the Menopausal Hot Flashes Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Menopausal Hot Flashes Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Menopausal Hot Flashes Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Menopausal Hot Flashes Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Menopausal Hot Flashes Market

A detailed market share analysis in the Menopausal Hot Flashes Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Menopausal Hot Flashes Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Menopausal Hot Flashes Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Menopausal Hot Flashes Market

A strategic analysis of the Menopausal Hot Flashes Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Menopausal Hot Flashes Market, highlighting leading vendors and their innovative profiles. These include A.Vogel Ltd., Apotex Inc., Astellas Pharma Inc., Bayer AG, Fervent Pharmaceuticals, LLC, Glenmark Pharmaceuticals Ltd., Mithra Pharmaceuticals, Novartis AG, Pfizer Inc., Teva Pharmaceuticals Ltd., TherapeuticsMD, Inc., and Zywie Ventures Private Limited.

Market Segmentation & Coverage

This research report categorizes the Menopausal Hot Flashes Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Treatment Type, market is studied across Alternative Treatment, Hormonal Treatment, and Non-Hormonal Treatment. The Alternative Treatment is further studied across Black Cohosh, Herbal Medicines, and Vitamin E. The Hormonal Treatment is further studied across Estrogen, Estrogen-Progesterone Combination, and Progesterone.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of menstrual fever
      • 5.1.1.2. Increasing awareness of menopause health among consumers
    • 5.1.2. Restraints
      • 5.1.2.1. Associated side effects of hormonal products
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of technologically advanced treatment
      • 5.1.3.2. Emerging awareness programs and campaigns for menopausal transition
    • 5.1.4. Challenges
      • 5.1.4.1. Presence of generic medicines
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Menopausal Hot Flashes Market, by Treatment Type

  • 6.1. Introduction
  • 6.2. Alternative Treatment
    • 6.2.1. Black Cohosh
    • 6.2.2. Herbal Medicines
    • 6.2.3. Vitamin E
  • 6.3. Hormonal Treatment
    • 6.3.1. Estrogen
    • 6.3.2. Estrogen-Progesterone Combination
    • 6.3.3. Progesterone
  • 6.4. Non-Hormonal Treatment

7. Menopausal Hot Flashes Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Hospital Pharmacies
  • 7.3. Online Pharmacies
  • 7.4. Retail Pharmacies

8. Americas Menopausal Hot Flashes Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Menopausal Hot Flashes Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Menopausal Hot Flashes Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. A.Vogel Ltd.
  • 2. Apotex Inc.
  • 3. Astellas Pharma Inc.
  • 4. Bayer AG
  • 5. Fervent Pharmaceuticals, LLC
  • 6. Glenmark Pharmaceuticals Ltd.
  • 7. Mithra Pharmaceuticals
  • 8. Novartis AG
  • 9. Pfizer Inc.
  • 10. Teva Pharmaceuticals Ltd.
  • 11. TherapeuticsMD, Inc.
  • 12. Zywie Ventures Private Limited

LIST OF FIGURES

  • FIGURE 1. MENOPAUSAL HOT FLASHES MARKET RESEARCH PROCESS
  • FIGURE 2. MENOPAUSAL HOT FLASHES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES MENOPAUSAL HOT FLASHES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES MENOPAUSAL HOT FLASHES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. MENOPAUSAL HOT FLASHES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. MENOPAUSAL HOT FLASHES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MENOPAUSAL HOT FLASHES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MENOPAUSAL HOT FLASHES MARKET DYNAMICS
  • TABLE 7. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY BLACK COHOSH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY HERBAL MEDICINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY VITAMIN E, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY ESTROGEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY ESTROGEN-PROGESTERONE COMBINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY PROGESTERONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY NON-HORMONAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES MENOPAUSAL HOT FLASHES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 191. MENOPAUSAL HOT FLASHES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. MENOPAUSAL HOT FLASHES MARKET, FPNV POSITIONING MATRIX, 2023